Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avid Bioservices Inc
(NQ:
CDMO
)
7.670
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Avid Bioservices Inc
< Previous
1
2
3
4
Next >
Avid Bioservices Earnings Preview
December 06, 2023
Via
Benzinga
Alaska Air, Orthofix Medical And Other Big Stocks Moving Lower In Monday's Pre-Market Session
December 04, 2023
U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Uber Will Join The S&P 500 Index. The Stock Is Jumping.
December 01, 2023
The ride-hailing giant will join the index as part of a quarterly rebalancing.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For September 7, 2023
September 07, 2023
Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $1.60 per share on revenue of $174.10 million.
Via
Benzinga
Earnings Outlook For Avid Bioservices
September 06, 2023
Via
Benzinga
Why Shares of Avid Bioservices Are Dropping Thursday
June 22, 2023
The CDMO released fourth-quarter and fiscal 2023 earnings.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Why Avid Bioservices Stock Was Plummeting This Week
June 23, 2023
The specialty healthcare services provider had a fiscal fourth quarter to forget.
Via
The Motley Fool
Avid Bioservices's Return on Invested Capital Overview
June 22, 2023
Via
Benzinga
Earnings Preview For Avid Bioservices
June 20, 2023
Via
Benzinga
Why Avid Bioservices Stock Is Surging Today
March 14, 2023
The bio-manufacturer's ongoing expansion efforts are a hit with investors.
Via
The Motley Fool
Avid Bioservice's FY24 Shortfall Anticipated: Analyst Says Later Stage Backlog May Pay In Longer Run
June 22, 2023
Wednesday afternoon Avid Bioservices Inc (NASDAQ: CDMO) reported Q4 revenue of $39.8 million, a 28% Y/Y, beating the co
Via
Benzinga
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
June 22, 2023
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to...
Via
Benzinga
Tech-Heavy Nasdaq Firmly Higher Midday
June 22, 2023
Stocks are attempting a rebound this afternoon, following their third-straight day of losses.
Via
Talk Markets
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
June 22, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P...
Via
Benzinga
US Stocks Lower Following Initial Jobless Claims Report
June 22, 2023
U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell...
Via
Benzinga
Avid Bioservices Earnings Preview
March 10, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
January 23, 2023
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 22, 2023
Via
Benzinga
Earnings Scheduled For June 21, 2023
June 21, 2023
Companies Reporting Before The Bell • iHuman (NYSE:IH) is projected to report earnings for its first quarter.
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
April 04, 2023
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
Dow Extends Rebound, Surges 456 Points
March 14, 2023
Rallying bank stocks are fueling Wall Street's midday gains, as investors continue to unpack this morning's consumer price index (CPI) data.
Via
Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 14, 2023
Via
Benzinga
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 14, 2023
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
March 14, 2023
Via
Benzinga
First Republic Bank, PacWest Bancorp, Western Alliance Bancorporation And Other Big Stocks Moving Higher On Tuesday
March 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
United Natural Foods, Ollie's Bargain, Smith & Wesson Brands And Some Other Big Stocks Moving Lower On Wednesday
December 07, 2022
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Earnings Scheduled For December 6, 2022
December 06, 2022
Companies Reporting Before The Bell • AutoZone (NYSE:AZO) is projected to report quarterly earnings at $25.27 per share on revenue of $3.86 billion.
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.